HARMONY BIOSCIENCES HOLDINGS (HRMY)

US4131971040 - Common Stock

34.28  +0.39 (+1.15%)

After market: 34.28 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
305.4M
91.23%		437.9M
43.39%		582.022M
32.91%		726.54M
24.83%		862.14M
18.66%		1.057B
22.60%		1.248B
18.07%		1.552B
24.36%		673M
-56.64%		453.8M
-32.57%		309.77M
-31.74%
EBITDA
YoY % growth
106.3M
292.25%		143.6M
35.09%		216.389M
50.69%		238.44M
10.19%		320.16M
34.27%		395.09M
23.40%		445.64M
12.79%		630.36M
41.45%		712.57M
13.04%		486.44M
-31.73%		279.48M
-42.55%
EBIT
YoY % growth
87.5M
417.75%		120.2M
37.37%		192.03M
59.76%		201.89M
5.13%		259.15M
28.36%		378.36M
46.00%		513.67M
35.76%		810.08M
57.70%		200.53M
-75.25%		67.116M
-66.53%		37.128M
-44.68%
Operating Margin
28.65%27.45%32.99%27.79%30.06%35.80%41.16%52.20%29.80%14.79%11.99%
EPS
YoY % growth
0.83
239.10%		3.13
277.11%		2.42
-22.68%		2.35
-2.88%		3.25
38.44%		4.83
48.34%		8.15
68.85%		9.16
12.39%		4.09
-55.35%		1.67
-59.10%		1.01
-39.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.73
62.55%		0.65
-3.18%		0.72
259.04%		0.75
-5.42%		0.79
8.42%
Revenue
Q2Q % growth		202.55M
20.27%		186.06M
20.34%		206.59M
19.54%		223.72M
20.26%		238.1M
17.55%
EBITDA
Q2Q % growth		73.634M
14.06%		75.072M
29.09%		83.905M
65.73%		93.707M
17.35%		99.827M
35.57%
EBIT
Q2Q % growth		59.913M
49.05%		55.855M
7.35%		62.096M
61.49%		68.681M
11.30%		73.127M
22.06%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 0.79
5.33%		0.680.1116.47%
Q2 2024
Q2Q % growth		 0.20
-64.29%		-0.060.26409.61%
Q1 2024
Q2Q % growth		 0.67
1.52%		0.620.058.70%
Q4 2023
Q2Q % growth		 0.45
-43.04%		0.49-0.04-7.85%
Q3 2023
Q2Q % growth		 0.75
-47.92%		0.660.0913.12%
Q2 2023
Q2Q % growth		 0.56
43.59%		0.65-0.09-13.20%
Q1 2023
Q2Q % growth		 0.66
29.41%		0.480.1837.31%
Q4 2022
Q2Q % growth		 0.79
107.89%		0.590.2033.82%
Q3 2022
Q2Q % growth		 1.44
947.06%		0.141.30951.28%
Q2 2022
Q2Q % growth		 0.39
62.50%		0.45-0.06-13.10%
Q1 2022
Q2Q % growth		 0.51
34.21%		0.300.2169.90%
Q4 2021
Q2Q % growth		 0.38
52.00%		0.360.024.45%
Q3 2021
Q2Q % growth		 -0.17
-21.43%		0.30-0.47-157.47%
Q2 2021
Q2Q % growth		 0.24 0.180.0633.18%
Q1 2021
Q2Q % growth		 0.38 -0.030.411,496.88%
Q4 2020
Q2Q % growth		 0.25 0.090.16172.33%
Q3 2020
Q2Q % growth		 -0.14 -0.05-0.09-174.51%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 186.038M
16.08%		187.74M-1.702M-0.91%
Q2 2024
Q2Q % growth		 172.814M
28.76%		175.98M-3.166M-1.80%
Q1 2024
Q2Q % growth		 154.615M
29.79%		157.18M-2.565M-1.63%
Q4 2023
Q2Q % growth		 168.412M
31.26%		172.44M-4.028M-2.34%
Q3 2023
Q2Q % growth		 160.268M
36.75%		151.58M8.688M5.73%
Q2 2023
Q2Q % growth		 134.216M
25.44%		144.87M-10.654M-7.35%
Q1 2023
Q2Q % growth		 119.126M
39.66%		118.52M606K0.51%
Q4 2022
Q2Q % growth		 128.3M
40.68%		129.89M-1.59M-1.22%
Q3 2022
Q2Q % growth		 117.2M
45.23%		115.81M1.39M1.20%
Q2 2022
Q2Q % growth		 107M
44.99%		102.77M4.23M4.12%
Q1 2022
Q2Q % growth		 85.3M
42.88%		90.324M-5.024M-5.56%
Q4 2021
Q2Q % growth		 91.2M
61.99%		91.316M-116K-0.13%
Q3 2021
Q2Q % growth		 80.7M
76.97%		81.58M-880K-1.08%
Q2 2021
Q2Q % growth		 73.8M
94.21%		70.278M3.522M5.01%
Q1 2021
Q2Q % growth		 59.7M
201.52%		58.208M1.492M2.56%
Q4 2020
Q2Q % growth		 56.3M 52.891M3.409M6.45%
Q3 2020
Q2Q % growth		 45.6M 40.868M4.732M11.58%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -0.4% 0.24% 3.07%
Revenue0% 1% 0.16% 0.37%